The ETF receives a Hold rating (Zacks Rank 3) with solid fundamentals including low expense ratio (0.37%), reasonable performance (16.67% YTD), and good diversification with 104 holdings. However, it is not recommended as a strong buy, and competitors offer lower expense ratios.
IYH is presented as a viable alternative for investors seeking concentrated exposure to large-cap healthcare companies, but is disadvantaged by higher fees and less diversification. It may appeal to specific investor preferences despite higher costs.
Recommended as the better choice for most long-term investors due to lower expense ratio (0.37%), higher dividend yield (1.1%), broader diversification across 100 positions, lower volatility, and better downside protection during market turbulence.
Delivered stronger 1-year returns (28.8% vs 22.5%) and 5-year performance ($1,394 vs $1,329 on $1,000 invested), demonstrating superior recent performance in the U.S. healthcare market.
Broader diversification with 100 holdings, higher dividend yield (1.1%), lower volatility with smaller max drawdown (17.9%), and larger AUM ($3.9B). Better for conservative, income-focused investors.
Recommended as the better fund choice due to superior 3-year (19.9% vs 10%) and 5-year (11.9% vs 5.5%) annualized returns. Offers broader diversification with 100 holdings, larger AUM of $3.9B providing better liquidity, and more balanced exposure across healthcare subsectors.
Lower expense ratio (0.38%), higher dividend yield (1.1%), larger asset base ($3.7B), proven 25+ year track record surviving multiple market cycles, and recommended as stronger foundation for most long-term investors despite lower recent returns.
While IYH is presented as a viable healthcare ETF option with similar holdings and risk profiles, it is not recommended due to its higher expense ratio (0.38%) and underperformance relative to FHLC across all measured time periods.
Articles that tag IYH but are mainly about other companies.
Positioned for gains from potential healthcare policy improvements and ACA subsidy restoration under Democratic control.
The healthcare sector ETF declined 0.44% alongside broader market pressure, with no specific catalysts mentioned affecting the fund directly.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology